首页> 美国卫生研究院文献>BioMed Research International >Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Does a Normal Age-Adjusted D-Dimer Rule Out PE?
【2h】

Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Does a Normal Age-Adjusted D-Dimer Rule Out PE?

机译:肺栓塞预测中的年龄调整后的D-二聚体:正常的年龄调整后的D-二聚体是否排除PE?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decision rules (CDR), and D-dimer testing. There is still controversy regarding the role of D-dimer testing in low or intermediate risk patients. The objective of the study was to define the role of clinical decision rules and D-dimer testing in patients suspected of having a PE. Records of 894 patients referred for computed tomography pulmonary angiography (CTPA) at a University medical center were analyzed. The clinical decision rules overall had an ROC of approximately 0.70, while signs of DVT had the highest ROC (0.80). A low probability CDR coupled with a negative age-adjusted D-dimer largely excluded PE. The negative predictive value (NPV) of an intermediate CDR was 86–89%, while the addition of a negative D-dimer resulted in NPVs of 94%. Thus, in patients suspected of having a PE, a low or intermediate CDR does not exclude PE; however, in patients with an intermediate CDR, a normal age-adjusted D-dimer increases the NPV.
机译:肺栓塞(PE)的风险评估目前依赖于医师的判断,临床决策规则(CDR)和D-二聚体测试。关于D-二聚体测试在中低风险患者中的作用仍存在争议。这项研究的目的是确定临床决策规则和D-二聚体检测在怀疑患有PE的患者中的作用。分析了在大学医学中心接受计算机断层扫描肺血管造影(CTPA)的894例患者的记录。总体而言,临床决策规则的ROC约为0.70,而DVT的体征ROC最高(0.80)。低概率CDR加上年龄校正的D-二聚体阴性,很大程度上排除了PE。中间CDR的阴性预测值(NPV)为86-89%,而添加阴性D-二聚体导致NPV达到94%。因此,在怀疑患有PE的患者中,低或中等CDR并不排除PE。但是,在具有中等CDR的患者中,正常的年龄校正D-二聚体会增加NPV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号